🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Safety immune response of Novartis MenACWY-CRM conjugate vaccine when given...
Status
Completed
Location
Site 85 - Birmingham Pediatric Associates, 806 St. Vincent's Drive
Start Date
2008-02
Trial ID
NCT00626327
Treatments Being Tested
A prospective, multisite study to evaluate the Impact of Measles, Mumps, Ru...
Status
Completed
Location
Medical University of South Carolina, Pediatric Nephrology
Start Date
2015-12
Trial ID
NCT02687763
Treatments Being Tested
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
The primary study objectives are: * To demonstrate that a 2-dose regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-29
Trial ID
NCT00566527
Treatments Being Tested
The purpose of this study is provide a better understanding of the adaptive...
Status
Completed
Location
Stanford University
Start Date
2014-09-30
Trial ID
NCT03453801
This clinical trial will evaluate the safety of two injections of Menactra®...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00483574
Healthy children who received two doses of GlaxoSmithKline (GSK) Biological...
Status
Unknown
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT02712203
Treatments Being Tested
This study will assess the safety and immunogenicity of ProQuad when admini...
Status
Completed
Location
Multiple Locations
Start Date
2000-06
Trial ID
NCT00984295
An observer-blind study to evaluate GlaxoSmithKline Biologicals' live atten...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-09-01
Trial ID
NCT00226499
Treatments Being Tested
The proposed study is an Extension Study of V72P13 to Evaluate the Safety, ...
Status
Completed
Location
Altenburger
Start Date
2009-02
Trial ID
NCT00847145
Treatments Being Tested